BIOCIENCIAS: Bª Y CLÍNICA DEL CÁNCER Y MEDIC. TRASLACIONAL
Escuela de doctorado
University of Paris-Sorbonne
París, FranciaPublicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (20)
2024
-
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells
Science Immunology, Vol. 9, Núm. 91
2023
-
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet, Vol. 401, Núm. 10373, pp. 269-280
-
Soluble endoglin reduces thrombus formation and platelet aggregation via interaction with αIIbβ3 integrin
Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 7, pp. 1943-1956
2022
-
Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022
Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 6, pp. 1855-1865
-
Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models
Frontiers in Medicine, Vol. 9
-
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Blood, Vol. 140, Núm. 11, pp. 1200-1228
-
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 2039-2051
-
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
Liver International, Vol. 42, Núm. 8, pp. 1891-1901
-
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 1986-1998.e2
2021
-
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 6, pp. 2139-2144
-
Contemporary Management of Severe Symptomatic Aortic Stenosis
Journal of the American College of Cardiology, Vol. 78, Núm. 22, pp. 2131-2143
-
Endoglin is an endothelial housekeeper against inflammation: Insight in ECFC-related permeability through LIMK/cofilin pathway
International Journal of Molecular Sciences, Vol. 22, Núm. 16
-
GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness
Blood, Vol. 138, Núm. 17, pp. 1590-1602
-
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions
HemaSphere, Vol. 5, Núm. 3, pp. E536
-
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 11, pp. 3918-3928
2020
-
A reference map of the human binary protein interactome
Nature, Vol. 580, Núm. 7803, pp. 402-408
-
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts
Theranostics, Vol. 10, Núm. 23, pp. 10743-10768
-
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
Journal of Allergy and Clinical Immunology, Vol. 146, Núm. 2, pp. 300-306
2016
-
Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry
Journal of the American Heart Association, Vol. 5, Núm. 10
2015
-
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Nature Genetics, Vol. 47, Núm. 2, pp. 164-171